Sign up
Quantellect · Congress · Trade Detail
NYSE: DGXQuest Diagnostics Incorporated
DemocratHouse

Ro Khanna sold Quest Diagnostics Incorporated (NYSE: DGX)

Ro Khanna (D-CA), a U.S. Representative, has disclosed 19 trades in Quest Diagnostics Incorporated (DGX) since 2015, 11 purchases and 8 sales, worth an estimated $177K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Ro Khanna sold $1,001 - $15,000 of Quest Diagnostics Incorporated (NYSE: DGX) on November 12, 2024. Since that trade, DGX is up +49.54% against the S&P 500 up +24.40%, an outperformance of +25.14%.

Across these filings, Ro Khanna has been a net buyer of DGX (a buy-to-sell ratio of 1.38). The most recent disclosed DGX transaction shown was dated February 17, 2026. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

DGX trades
19
Disclosed Vol
$177K
Buys
11
58%
Sells
8
42%
Buy / Sell
1.38
ratio
First → Last
2015–2026

Ro Khanna's DGX trades vs the price

DGX is up +49.54% since Ro Khanna sold on November 12, 2024, versus +24.40% for the S&P 500.

Performance since this trade

Price change since trade
+49.54%
S&P 500 change since trade
+24.40%
Outperformance vs S&P 500
+25.14%

All Ro Khanna DGX trades

TradedTypeSizeReturnEst. profit
February 17, 2026SELL$204.60+14.96%
January 29, 2026BUY$181.56+29.55%+$2K
January 17, 2025BUY$147.80+59.15%+$4K
December 18, 2024SELL$147.13+59.87%
December 16, 2024SELL$148.49+58.41%
November 15, 2024SELL$156.07+50.71%
November 12, 2024SELL$157.30+49.54%
February 13, 2024BUY$122.40+92.17%+$7K
February 13, 2024BUY$122.40+92.17%+$7K
December 5, 2023BUY$128.45+83.12%+$6K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Ro Khanna & DGX trading FAQ

Is it legal for Ro Khanna to trade Quest Diagnostics Incorporated (DGX) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Quest Diagnostics Incorporated (DGX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Ro Khanna sell DGX?

Ro Khanna disclosed a sale of $1,001 - $15,000 of Quest Diagnostics Incorporated (DGX) on November 12, 2024, according to public STOCK Act filings.

How has DGX performed since Ro Khanna's trade?

Since Ro Khanna sold DGX on November 12, 2024, the stock is up +49.54%, versus +24.40% for the S&P 500 over the same period, an outperformance of +25.14%.

How many times has Ro Khanna traded DGX?

Ro Khanna has disclosed 19 DGX trades since 2015 (11 purchases and 8 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional DGX trades?

Quantellect tracks every disclosed congressional trade in Quest Diagnostics Incorporated (DGX) on the Quest Diagnostics Incorporated congressional trading page, which aggregates filings across all members of Congress.

Ro Khanna's DGX tradesAll congressional filings for Quest Diagnostics IncorporatedRo Khanna's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.